BioCanRx deals with translation, manufacture and adoption of cancer immunotherapies.
BioCanRx has raised $38.0M in total funding. The most recent round was Grant. The last funding was announced in December 2023.
BioCanRx's investors include Innovation, Science and Economic Development Canada.
BioCanRx is headquartered in Ottawa, Canada.
BioCanRx deals with translation, manufacture and adoption of cancer immunotherapies.
BioCanRx is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioCanRx — Funding & Investors." VCBacked, December 6, 2023, https://www.vcbacked.co/company/biocanrx. Accessed September 30, 2026.
VCBacked. (2023). BioCanRx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biocanrx
{{cite web |title=BioCanRx — Funding & Investors |url=https://www.vcbacked.co/company/biocanrx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated